Clinical trial
A Study of an Investigational Zoster Vaccine, in Subjects With a History of…
NCT00322231 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00322231 |
|---|---|
| Title | A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014) |
| Official title | A Phase III Clinical Trial to Study the Safety, Tolerability and Immunogenicity of Zoster Vaccine Live in Subjects With a History of Herpes Zoster |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Zoster |
| Intervention type | Biological |
| Interventions | zoster vaccine live (ZOSTAVAX™), Comparator: Placebo |
| Enrollment | 101 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | May 5, 2006 |
| Last update posted | Jan 26, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: